Reduced Medicare reimbursement rates is being cited as the main reason iRhythm’s stock has tumbled, but is there more to the story than reimbursement?
- Pain Points When Maintaining a Cleanroom
- Manufacturing Durable Diabetes Tech for the 21st Century
- Innovation in Patient Monitoring and Wearables
- More Layoffs Signal COVID-19 Testing Boom Is Over
- Increasing COVID Numbers in China Creates Uncertainty
- High-Quality (Level 4) PMCF Surveys: What Are They?